5.
Multivariate analysis of baseline factors associated with selection of docetaxel/anthracycline sequential therapy
| Factor | Odds ratio | 95% CI | P |
| 95% CI, 95% confidence interval. | |||
| Age group (year) | |||
| 40–<65vs. <40 | 1.098 | (0.794, 1.519) | 0.572 |
| ≥65 vs. <40 | 0.418 | (0.219, 0.798) | 0.008 |
| Estrogen receptor status | |||
| Positive vs. negative | 0.681 | (0.535, 0.867) | 0.002 |
| Unknown vs. negative | 0.816 | (0.288, 2.317) | 0.703 |